top of page
< Back

Alogliptin

阿格列汀

Mechanism of action:

Alogliptin 抑制體內 DPP-4 酵素的活性,使腸泌素(incretins)如 GLP-1(glucagon-like peptide-1)與 GIP(glucose-dependent insulinotropic polypeptide)不會被 DPP-4 分解,來延長腸泌素在血液中的存在時間。這些腸泌素能促進胰島 β 細胞的葡萄糖依賴性胰島素分泌以及抑制胰島 α 細胞釋放升糖素(glucagon)。

​Reference(s):

Andukuri R et al. (2009). Alogliptin: a new addition to the class of DPP-4 inhibitors. Diabetes Metab Syndr Obes.

bottom of page